Tag: sanofi
-
Sanofi ready to up offer for drugmaker Medivation, could oust board
PARIS/NEW YORK (Reuters) – France's Sanofi said it could raise its proposed $9.3 billion deal to buy Medivation if the U.S. cancer drugmaker engaged in talks, threatening to go directly to shareholders to oust the board if not. Sanofi Chief Executive Olivier Brandicourt wrote in a letter to the board of Medivation published on Thursday…
-
Sanofi, Amgen cholesterol drugs win UK backing after price cuts
Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the manufacturers offered special discounts to the country's state-run health service. Sanofi's Praluent, which was developed with Regeneron, and Amgen's Repatha are both so-called PCSK9 medicines that work in a different way to existing cholesterol fighters such as…
-
Sanofi pledges stable 2016 earnings
By Matthias Blamont and Noëlle Mennella PARIS (Reuters) – Sanofi said it expected stable earnings per share this year after reporting lower fourth-quarter income on Tuesday, hurt by declining sales of diabetes and cancer treatments and other prescription drugs. The French drugmaker, which is in the midst of a reorganisation to address falling sales of…
-
Drugged up: GSK, Roche and Sanofi to set out their stalls
By Ben Hirschler LONDON (Reuters) – Three of Europe's top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. GSK's Andrew Witty and Sanofi's new boss Olivier Brandicourt both need to demonstrate recovery potential, after recent disappointments, while Roche's Severin…
-
Factbox: Drugs to watch at Roche, Sanofi and GSK
(Reuters) – GlaxoSmithKline, Roche and Sanofi all hold investor days this week. Below are three new drugs to watch from each company, with consensus annual sales in 2020, according to Thomson Reuters Cortellis. …